Evidence map›Paper›PMID 24951806›Full record

ArticleJournal of clinical microbiology2014

Improved sensitivity for molecular detection of bacterial and Candida infections in blood.

Andrea Bacconi, Gregory S Richmond, Michelle A Baroldi, Thomas G Laffler, Lawrence B Blyn, Heather E Carolan, Mark R Frinder, Donna M Toleno, David Metzgar, Jose R Gutierrez and 9 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 169 citations in OpenAlex.

  1. Nucleic Acid Amplification Tests forPathogens (Basel, Switzerland) · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. A MALDI-TOF nucleic acid mass spectrometry assay for rapid detection of fiveFrontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Rapid and sensitive identification ofFrontiers in cellular and infection microbiology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Photo-Fenton and TiOMolecules (Basel, Switzerland) · 2023
    Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Andrea BacconiIbis Biosciences, Inc., Carlsbad, California, USA.
Gregory S RichmondIbis Biosciences, Inc., Carlsbad, California, USA.
Michelle A BaroldiIbis Biosciences, Inc., Carlsbad, California, USA.
Thomas G LafflerIbis Biosciences, Inc., Carlsbad, California, USA.
Lawrence B BlynIbis Biosciences, Inc., Carlsbad, California, USA.
Heather E CarolanIbis Biosciences, Inc., Carlsbad, California, USA.
Mark R FrinderIbis Biosciences, Inc., Carlsbad, California, USA.
Donna M TolenoIbis Biosciences, Inc., Carlsbad, California, USA.
David MetzgarIbis Biosciences, Inc., Carlsbad, California, USA.
Jose R GutierrezIbis Biosciences, Inc., Carlsbad, California, USA.
Christian MassireIbis Biosciences, Inc., Carlsbad, California, USA.
Megan RoundsIbis Biosciences, Inc., Carlsbad, California, USA.
Natalie J KennelIbis Biosciences, Inc., Carlsbad, California, USA.
Richard E RothmanDepartment of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Stephen PetersonDepartment of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Karen C CarrollThe Johns Hopkins Hospital Clinical Microbiology Laboratory, Baltimore, Maryland, USA.
Teresa WakefieldThe Johns Hopkins Hospital Clinical Microbiology Laboratory, Baltimore, Maryland, USA.
David J EckerIbis Biosciences, Inc., Carlsbad, California, USA.
Rangarajan SampathIbis Biosciences, Inc., Carlsbad, California, USA rangarajan.sampath@abbott.com.ORCID http://orcid.org/0000-0002-2951-6372
Ionis Pharmaceuticals (United States) · USJohns Hopkins Hospital · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI GEDDES, CHRISTOPHER DARREN · 2003 to 2013
$91.5M
NIAID NIH HHS U54 AI057168
6 · The paper itself

Abstract

The rapid identification of bacteria and fungi directly from the blood of patients with suspected bloodstream infections aids in diagnosis and guides treatment decisions. The development of an automated, rapid, and sensitive molecular technology capable of detecting the diverse agents of such infections at low titers has been challenging, due in part to the high background of genomic DNA in blood. PCR followed by electrospray ionization mass spectrometry (PCR/ESI-MS) allows for the rapid and accurate identification of microorganisms but with a sensitivity of about 50% compared to that of culture when using 1-ml whole-blood specimens. Here, we describe a new integrated specimen preparation technology that substantially improves the sensitivity of PCR/ESI-MS analysis. An efficient lysis method and automated DNA purification system were designed for processing 5 ml of whole blood. In addition, PCR amplification formulations were optimized to tolerate high levels of human DNA. An analysis of 331 specimens collected from patients with suspected bloodstream infections resulted in 35 PCR/ESI-MS-positive specimens (10.6%) compared to 18 positive by culture (5.4%). PCR/ESI-MS was 83% sensitive and 94% specific compared to culture. Replicate PCR/ESI-MS testing from a second aliquot of the PCR/ESI-MS-positive/culture-negative specimens corroborated the initial findings in most cases, resulting in increased sensitivity (91%) and specificity (99%) when confirmed detections were considered true positives. The integrated solution described here has the potential to provide rapid detection and identification of organisms responsible for bloodstream infections.

Indexed as

AdolescentAdultAutomation, LaboratoryBacteremiaBloodCandidemiaFemaleHumansMaleMolecular Diagnostic TechniquesPolymerase Chain ReactionProspective StudiesSensitivity and SpecificitySpecimen HandlingSpectrometry, Mass, Electrospray IonizationYoung Adult

Identifiers

PMID24951806
PMCPMC4313132
OpenAlexW2120267328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.